Viewing Study NCT03120832


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-02-27 @ 12:49 AM
Study NCT ID: NCT03120832
Status: COMPLETED
Last Update Posted: 2021-11-12
First Post: 2017-02-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients
Sponsor: Sensei Biotherapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PAN0216
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View